Robert P Schleimer, MD, PhD
Disclosures: Consulting Fee-Actobio Therapeutics|Consulting Fee-Allakos|Stock-Allakos|Receipt of Intellectual Property Rights/Patent Holder-Allakos|Consulting Fee-Aqualung Therapeutics Corp |Stock-Aqualung Therapeutics Corp |Consulting Fee-Astellas Pharm Inc|Consulting Fee-AstraZeneca|Consulting Fee-Aurasense|Stock-Aurasense|Consulting Fee-BioMarck|Stock-BioMarck|Consulting Fee-Celgene Corp|Consulting Fee-Exicure|Stock-Exicure|Consulting Fee-Genentech, Inc.|Consulting Fee-Genzyme Corporation|Consulting Fee-GlaxoSmithKline|Consulting Fee-Intersect ENT|Consulting Fee-Lyra Therapeutics|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Otsuka America Pharmaceutical, Inc.|Consulting Fee-Sanofi-Aventis
No Bio Available.